BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25996166)

  • 1. The molecular pathogenesis of B-cell non-Hodgkin lymphoma.
    Blombery PA; Wall M; Seymour JF
    Eur J Haematol; 2015 Oct; 95(4):280-93. PubMed ID: 25996166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
    Chung C
    J Oncol Pharm Pract; 2020 Jun; 26(4):943-966. PubMed ID: 31964218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma.
    Cerosaletti KM; Morrison VA; Sabath DE; Willerford DM; Concannon P
    Genes Chromosomes Cancer; 2002 Nov; 35(3):282-6. PubMed ID: 12353271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of non-Hodgkin's lymphoma.
    Nogai H; Dörken B; Lenz G
    J Clin Oncol; 2011 May; 29(14):1803-11. PubMed ID: 21483013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?
    Ferrucci PF; Zucca E
    Br J Haematol; 2007 Feb; 136(4):521-38. PubMed ID: 17156403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
    Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
    Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
    Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
    Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin Lymphomas: Malignancies Arising from Mature B Cells.
    Shingleton J; Wang J; Baloh C; Dave T; Davis N; Happ L; Jadi O; Kositsky R; Li X; Love C; Panea R; Qin Q; Reddy A; Singhi N; Smith E; Thakkar D; Dave SS
    Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32152246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches.
    Sandlund JT; Perkins SL
    Br J Haematol; 2015 Jun; 169(5):631-46. PubMed ID: 25851546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
    García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
    Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma.
    Ong ST; Le Beau MM
    Semin Oncol; 1998 Aug; 25(4):447-60. PubMed ID: 9728595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis.
    Capello D; Martini M; Gloghini A; Cerri M; Rasi S; Deambrogi C; Rossi D; Spina M; Tirelli U; Larocca LM; Carbone A; Gaidano G
    Haematologica; 2008 Aug; 93(8):1178-85. PubMed ID: 18556404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly identified mechanisms in B-cell non-Hodgkin lymphomas uncovered by next-generation sequencing.
    Morin RD; Gascoyne RD
    Semin Hematol; 2013 Oct; 50(4):303-13. PubMed ID: 24246698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma.
    Mihara K; Yanagihara K; Takigahira M; Imai C; Kitanaka A; Takihara Y; Kimura A
    J Immunother; 2009 Sep; 32(7):737-43. PubMed ID: 19561535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
    Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
    J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma.
    Moffitt AB; Dave SS
    J Clin Oncol; 2017 Mar; 35(9):955-962. PubMed ID: 28297626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
    Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
    J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.